A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults
Clinical trial NCT03814590 · COMPLETED
Trial details
- NCT number
- NCT03814590
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-21
- Primary completion
- 2019-12-12
- Enrollment
- 1053
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.